1. Home
  2. MDAIW vs DOGZ Comparison

MDAIW vs DOGZ Comparison

Compare MDAIW & DOGZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDAIW
  • DOGZ
  • Stock Information
  • Founded
  • MDAIW N/A
  • DOGZ 2003
  • Country
  • MDAIW United States
  • DOGZ China
  • Employees
  • MDAIW 78
  • DOGZ N/A
  • Industry
  • MDAIW Medical/Dental Instruments
  • DOGZ Miscellaneous manufacturing industries
  • Sector
  • MDAIW Health Care
  • DOGZ Consumer Discretionary
  • Exchange
  • MDAIW Nasdaq
  • DOGZ Nasdaq
  • Market Cap
  • MDAIW N/A
  • DOGZ N/A
  • IPO Year
  • MDAIW N/A
  • DOGZ 2017
  • Fundamental
  • Price
  • MDAIW $0.37
  • DOGZ $25.74
  • Analyst Decision
  • MDAIW
  • DOGZ
  • Analyst Count
  • MDAIW 0
  • DOGZ 0
  • Target Price
  • MDAIW N/A
  • DOGZ N/A
  • AVG Volume (30 Days)
  • MDAIW 35.6K
  • DOGZ 304.1K
  • Earning Date
  • MDAIW 02-27-2025
  • DOGZ 06-06-2025
  • Dividend Yield
  • MDAIW N/A
  • DOGZ N/A
  • EPS Growth
  • MDAIW N/A
  • DOGZ N/A
  • EPS
  • MDAIW N/A
  • DOGZ N/A
  • Revenue
  • MDAIW $27,264,000.00
  • DOGZ $20,258,926.00
  • Revenue This Year
  • MDAIW N/A
  • DOGZ N/A
  • Revenue Next Year
  • MDAIW N/A
  • DOGZ N/A
  • P/E Ratio
  • MDAIW N/A
  • DOGZ N/A
  • Revenue Growth
  • MDAIW 44.52
  • DOGZ 46.16
  • 52 Week Low
  • MDAIW $0.08
  • DOGZ $9.61
  • 52 Week High
  • MDAIW $0.90
  • DOGZ $58.50
  • Technical
  • Relative Strength Index (RSI)
  • MDAIW N/A
  • DOGZ 72.08
  • Support Level
  • MDAIW N/A
  • DOGZ $21.01
  • Resistance Level
  • MDAIW N/A
  • DOGZ $24.30
  • Average True Range (ATR)
  • MDAIW 0.00
  • DOGZ 1.80
  • MACD
  • MDAIW 0.00
  • DOGZ 0.97
  • Stochastic Oscillator
  • MDAIW 0.00
  • DOGZ 100.00

About MDAIW Spectral AI Inc.

Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient's wound.

Share on Social Networks: